Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma

Ann Hematol. 2016 Mar;95(4):667-8. doi: 10.1007/s00277-016-2601-6. Epub 2016 Jan 23.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Bortezomib / administration & dosage*
  • Cyclophosphamide / administration & dosage
  • Dose-Response Relationship, Drug
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Humans
  • Infusions, Subcutaneous* / methods
  • Male
  • Plasmablastic Lymphoma / diagnosis*
  • Plasmablastic Lymphoma / drug therapy*
  • Prednisone / administration & dosage
  • Treatment Outcome
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Bortezomib
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • EPOCH protocol